UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | February 27, 2023 |
Accession Number: | 0001193125-23-046663 | ||||||
Submission Type: | POS AM | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | February 27, 2023 |
Accession Number: | 0001193125-23-046663 | ||||||
Submission Type: | POS AM | ||||||
|
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/12/2022 | $6.00 → $2.00 | Outperform → Neutral | Robert W. Baird |
3/9/2022 | $20.00 → $10.00 | Outperform | Northland Capital Markets |
3/9/2022 | $6.00 → $5.00 | Neutral | B of A Securities |
3/9/2022 | $15.00 → $8.00 | Buy | Needham |
12/22/2021 | $14.00 → $6.00 | Buy → Neutral | B of A Securities |
9/17/2021 | $14.00 | Buy | B of A Securities |
9/9/2021 | $22.00 | Outperform | Cowen |
9/7/2021 | $15.00 | Buy | Needham |
15-12G - Rockley Photonics Holdings Ltd (0001852117) (Filer)
10-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)
8-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)
Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear
Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha
Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and
Robert W. Baird downgraded Rockley Photonics from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously
Northland Capital Markets reiterated coverage of Rockley Photonics Hldgs with a rating of Outperform and set a new price target of $10.00 from $20.00 previously
B of A Securities reiterated coverage of Rockley Photonics Hldgs with a rating of Neutral and set a new price target of $5.00 from $6.00 previously